Evaluation of mass loss and muscular strength in hospitalized elderly
Not Applicable
- Conditions
- SarcopeniaagedM01.060.116.100C10.597.613.612.500
- Registration Number
- RBR-46gj9d
- Lead Sponsor
- niversidade Estadual de Ponta Grossa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Elderly people from 60 years of age; hospital admission of up to 48 hours; hospitalization time equal to or greater than 5 days; previous functional independence report
Exclusion Criteria
Seniors who can not carry out the proposed evaluations; which have: peripheral saturation less than 85%, heart rate less than 50 or greater than 140bpm before evaluation; respiratory rate greater than 35 ipm, temperature greater than 38 ° C and blood pressure variation in 20% of the current (for more or less)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in the degree of sarcopenia in the elderly with longer hospitalization
- Secondary Outcome Measures
Name Time Method Secondary outcomes are not expected
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways contribute to sarcopenia-related muscle atrophy in elderly hospitalized patients?
How does sarcopenia impact recovery outcomes compared to standard geriatric care protocols?
Which biomarkers predict sarcopenia progression in hospitalized older adults with comorbidities?
What adverse events are associated with sarcopenia in elderly inpatient populations?
How do RBR-46gj9d findings inform pharmacological strategies for sarcopenia management in elderly?